| For: | Yan LH, Wang XT, Yang J, Lian C, Kong FB, Wei WY, Luo W, Xiao Q, Xie YB. Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation. World J Gastroenterol 2013; 19(26): 4155-4165 [PMID: 23864778 DOI: 10.3748/wjg.v19.i26.4155] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i26/4155.htm |
| Number | Citing Articles |
| 1 |
Youngmi Kim, Hyuna Kim, Dooil Jeoung. Tubulin Beta3 Serves as a Target of HDAC3 and Mediates Resistance to Microtubule-Targeting Drugs. Molecules and Cells 2015; 38(8) doi: 10.14348/molcells.2015.0086
|
| 2 |
Rio Sumarni Shariffudin, Sabrina Azanan, Julia Guan Chin Hsien. Multiple Intelligence Multimedia Courseware (MIMCO)Based on the Constructivist-Contextual Model for the Learning of Some Chemistry Concepts. International Journal of Future Computer and Communication 2012; doi: 10.7763/IJFCC.2012.V1.9
|
| 3 |
Qiang Wang, Chunmei Zhang, Shengya Cao, Hongying Zhao, Rongke Jiang, Yanfang Li. Tumor-derived exosomes orchestrate the microRNA-128-3p/ELF4/CDX2 axis to facilitate the growth and metastasis of gastric cancer via delivery of LINC01091. Cell Biology and Toxicology 2023; 39(2) doi: 10.1007/s10565-022-09728-y
|
| 4 |
Nigatu Tadesse Gebrehiwot, Ying Liu, Juan Li, Hong-Min Liu. Molecular Alterations in Gastric Intestinal Metaplasia Shed Light on Alteration of Methionine Metabolism: Insight into New Diagnostic and Treatment Approaches. Biomedicines 2025; 13(4) doi: 10.3390/biomedicines13040964
|
| 5 |
Shaodong Zhong, Heng Zhang, Jin Huang. CDX2‑UPK1B‑PIK3IP1‑PI3K/AKT signaling axis regulates gastric cancer cell invasion and migration and influences patient prognosis. Experimental and Therapeutic Medicine 2026; 32(1) doi: 10.3892/etm.2026.13179
|
| 6 |
Mina Darvishi, Pargol Mashati, Abbas Khosravi. The clinical significance of CDX2 in leukemia: A new perspective for leukemia research. Leukemia Research 2018; 72 doi: 10.1016/j.leukres.2018.07.021
|
| 7 |
Bing Xu, Jinjuan Guo, Mei Chen. Circ_0017274 acts on miR‐637/CDX2 axis to facilitate cisplatin resistance in gastric cancer. Clinical and Experimental Pharmacology and Physiology 2022; 49(10) doi: 10.1111/1440-1681.13692
|
| 8 |
miR-135a promotes gastric cancer progression and resistance to oxaliplatin. Oncotarget 2016; 7(43) doi: 10.18632/oncotarget.12208
|
| 9 |
Pengfei Yu, Sunfu Fan, Ling Huang, Litao Yang, Yian Du. MIR210 as a potential molecular target to block invasion and metastasis of gastric cancer. Medical Hypotheses 2015; 84(3) doi: 10.1016/j.mehy.2014.12.024
|
| 10 |
Yi-Han Chiu, Shih-Hsien Hsu, Hsiao-Wei Hsu, Kuo-Chin Huang, Wangta Liu, Chang-Yi Wu, Wei-Pang Huang, Jeff Chen, Bing-Hung Chen, Chien-Chih Chiu. Human non‑small cell lung cancer cells can be sensitized to camptothecin by modulating autophagy. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4523
|
| 11 |
Dandan Chai, Huifen Du, Kesheng Li, Xueliang Zhang, Xiaoqin Li, Xiaoning Zhao, Xiaowen Lian, Yang Xu. CDX2 and Reg IV expression and correlation in gastric cancer. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01678-9
|
| 12 |
XIAOJUN YANG, HUI CAI, YUHE LIANG, LIN CHEN, XIANGDONG WANG, RUOHUANG SI, KUNPENG QU, ZEBIN JIANG, BINGQIANG MA, CHANGFENG MIAO, JING LI, BIN WANG, PENG GAO. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells. Oncology Reports 2015; 33(4) doi: 10.3892/or.2015.3757
|